Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy A Chan

Showing results (1-10 of 271) with videos related to

Pageof 28
Sort By:
The Lancet. Oncology|March 21, 2002
Nonsteroidal anti-inflammatory drugs, apoptosis, and colon-cancer chemopreventionTimothy A Chan
Current Cancer Drug Targets|December 20, 2003
Cyclooxygenase inhibition and mechanisms of colorectal cancer preventionTimothy A Chan
Trends in Molecular Medicine|May 3, 2006
Prostaglandins and the colon cancer connectionTimothy A Chan
Trends in Cancer|August 6, 2022
Solving the puzzle of what makes immunotherapies workXiaoxiao Ma, Timothy A Chan
Cell Cycle (Georgetown, Tex.)|December 9, 2014
Molecular mechanisms orchestrating cyclin stabilityYongxing Gong, Timothy A Chan
Cancer Discovery|April 24, 2016
Personalized Oncology Meets Immunology: The Path toward Precision ImmunotherapyRajarsi Mandal, Timothy A Chan
Nature Genetics|July 30, 2013
MAPping the genomic landscape of low-grade pediatric gliomasSevin Turcan, Timothy A Chan
Current Opinion in Genetics & Development|January 16, 2015
Immunogenic peptide discovery in cancer genomesAlexandra Snyder, Timothy A Chan
Genome Medicine|July 26, 2019
The good, the bad, and the ugly: hyperprogression in cancer patients following immune checkpoint therapyErich Sabio, Timothy A Chan
Cell Cycle (Georgetown, Tex.)|September 17, 2009
The protein tyrosine phosphatase receptor D, a broadly inactivated tumor suppressor regulating STAT functionTimothy A Chan, Adriana Heguy
Pageof 28

Showing results (1-10 of 271) with videos related to

Sort By:
Pageof 28
The Lancet. Oncology|March 21, 2002
Nonsteroidal anti-inflammatory drugs, apoptosis, and colon-cancer chemopreventionTimothy A Chan
Current Cancer Drug Targets|December 20, 2003
Cyclooxygenase inhibition and mechanisms of colorectal cancer preventionTimothy A Chan
Trends in Molecular Medicine|May 3, 2006
Prostaglandins and the colon cancer connectionTimothy A Chan
Trends in Cancer|August 6, 2022
Solving the puzzle of what makes immunotherapies workXiaoxiao Ma, Timothy A Chan
Cell Cycle (Georgetown, Tex.)|December 9, 2014
Molecular mechanisms orchestrating cyclin stabilityYongxing Gong, Timothy A Chan
Cancer Discovery|April 24, 2016
Personalized Oncology Meets Immunology: The Path toward Precision ImmunotherapyRajarsi Mandal, Timothy A Chan
Nature Genetics|July 30, 2013
MAPping the genomic landscape of low-grade pediatric gliomasSevin Turcan, Timothy A Chan
Current Opinion in Genetics & Development|January 16, 2015
Immunogenic peptide discovery in cancer genomesAlexandra Snyder, Timothy A Chan
Genome Medicine|July 26, 2019
The good, the bad, and the ugly: hyperprogression in cancer patients following immune checkpoint therapyErich Sabio, Timothy A Chan
Cell Cycle (Georgetown, Tex.)|September 17, 2009
The protein tyrosine phosphatase receptor D, a broadly inactivated tumor suppressor regulating STAT functionTimothy A Chan, Adriana Heguy
Pageof 28